Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | GABRP | O00591 | 5/20 | 0.35 |
| ▸ | GABRD | O14764 | 5/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 5/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 5/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 5/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 5/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 5/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.35 |
| ▸ | GABRA4 | P48169 | 5/20 | 0.35 |
| ▸ | GABRE | P78334 | 5/20 | 0.35 |
| ▸ | GABRA6 | Q16445 | 5/20 | 0.35 |
| ▸ | GABRG1 | Q8N1C3 | 5/20 | 0.35 |
| ▸ | GABRG3 | Q99928 | 5/20 | 0.35 |
| ▸ | GABRQ | Q9UN88 | 5/20 | 0.35 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6482141 | 0.87 | AHR (0.46) | LMNAKMT2AGABRPGABRDGABRA1 | |
| SCHEMBL6481811 | 0.84 | NFE2L2 (0.36) | MEN1LMNAKMT2AGABRPGABRD | |
| SCHEMBL6491290 | 0.75 | AHR (0.46) | LMNAKMT2AGABRPGABRDGABRA1 | |
| SCHEMBL25011813 | 0.74 | GABRP (0.52) | MEN1LMNAKMT2AGABRPGABRD | |
| SCHEMBL6483782 | 0.74 | AHR (0.45) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL6494130 | 0.73 | CYP1A1 (0.36) | MEN1LMNAKMT2AGABRPGABRD | |
| SCHEMBL6482701 | 0.73 | CYP1A2 (0.47) | MEN1LMNAKMT2AGABRPGABRD | |
| SCHEMBL6497744 | 0.72 | AHR (0.44) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL6483496 | 0.71 | AHR (0.45) | LMNAKMT2AGABRPGABRDGABRA1 | |
| SCHEMBL6493354 | 0.70 | NFE2L2 (0.42) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050075332-A1 | Tricyclic compounds with antiviral activity | WARNER LAMBERT COMPANY | 2005-04-07 | — | — | US | claimed |
| US-20050075332-A1 | Tricyclic compounds with antiviral activity | WARNER LAMBERT COMPANY | 2005-04-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075332-A1 | Tricyclic compounds with antiviral activity | HDAC8, CDK8, ZC3HAV1 | MEN1 3464/4885LMNA 4305/4885KMT2A 770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.